Cargando…
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
INTRODUCTION: In this study of preclinical Alzheimer’s disease (AD) we assessed the added diagnostic value of using cerebrospinal fluid (CSF) Aβ ratios rather than Aβ42 in isolation for detecting individuals who are positive on amyloid positron emission tomography (PET). METHODS: Thirty-eight commun...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683859/ https://www.ncbi.nlm.nih.gov/pubmed/26677842 http://dx.doi.org/10.1186/s13195-015-0159-5 |
_version_ | 1782406100135444480 |
---|---|
author | Adamczuk, Katarzyna Schaeverbeke, Jolien Vanderstichele, Hugo M. J. Lilja, Johan Nelissen, Natalie Van Laere, Koen Dupont, Patrick Hilven, Kelly Poesen, Koen Vandenberghe, Rik |
author_facet | Adamczuk, Katarzyna Schaeverbeke, Jolien Vanderstichele, Hugo M. J. Lilja, Johan Nelissen, Natalie Van Laere, Koen Dupont, Patrick Hilven, Kelly Poesen, Koen Vandenberghe, Rik |
author_sort | Adamczuk, Katarzyna |
collection | PubMed |
description | INTRODUCTION: In this study of preclinical Alzheimer’s disease (AD) we assessed the added diagnostic value of using cerebrospinal fluid (CSF) Aβ ratios rather than Aβ42 in isolation for detecting individuals who are positive on amyloid positron emission tomography (PET). METHODS: Thirty-eight community-recruited cognitively intact older adults (mean age 73, range 65–80 years) underwent (18)F-flutemetamol PET and CSF measurement of Aβ1-42, Aβ1-40, Aβ1-38, and total tau (ttau). (18)F-flutemetamol retention was quantified using standardized uptake value ratios in a composite cortical region (SUVR(comp)) with reference to cerebellar grey matter. Based on a prior autopsy validation study, the SUVR(comp) cut-off was 1.57. Sensitivities, specificities and cut-offs were defined based on receiver operating characteristic analysis with CSF analytes as variables of interest and (18)F-flutemetamol positivity as the classifier. We also determined sensitivities and CSF cut-off values at fixed specificities of 90 % and 95 %. RESULTS: Seven out of 38 subjects (18 %) were positive on amyloid PET. Aβ42/ttau, Aβ42/Aβ40, Aβ42/Aβ38, and Aβ42 had the highest accuracy to identify amyloid-positive subjects (area under the curve (AUC) ≥ 0.908). Aβ40 and Aβ38 had significantly lower discriminative power (AUC = 0.571). When specificity was fixed at 90 % and 95 %, Aβ42/ttau had the highest sensitivity among the different CSF markers (85.71 % and 71.43 %, respectively). Sensitivity of Aβ42 alone was significantly lower under these conditions (57.14 % and 42.86 %, respectively). CONCLUSION: For the CSF-based definition of preclinical AD, if a high specificity is required, our data support the use of Aβ42/ttau rather than using Aβ42 in isolation. |
format | Online Article Text |
id | pubmed-4683859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46838592015-12-19 Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease Adamczuk, Katarzyna Schaeverbeke, Jolien Vanderstichele, Hugo M. J. Lilja, Johan Nelissen, Natalie Van Laere, Koen Dupont, Patrick Hilven, Kelly Poesen, Koen Vandenberghe, Rik Alzheimers Res Ther Research INTRODUCTION: In this study of preclinical Alzheimer’s disease (AD) we assessed the added diagnostic value of using cerebrospinal fluid (CSF) Aβ ratios rather than Aβ42 in isolation for detecting individuals who are positive on amyloid positron emission tomography (PET). METHODS: Thirty-eight community-recruited cognitively intact older adults (mean age 73, range 65–80 years) underwent (18)F-flutemetamol PET and CSF measurement of Aβ1-42, Aβ1-40, Aβ1-38, and total tau (ttau). (18)F-flutemetamol retention was quantified using standardized uptake value ratios in a composite cortical region (SUVR(comp)) with reference to cerebellar grey matter. Based on a prior autopsy validation study, the SUVR(comp) cut-off was 1.57. Sensitivities, specificities and cut-offs were defined based on receiver operating characteristic analysis with CSF analytes as variables of interest and (18)F-flutemetamol positivity as the classifier. We also determined sensitivities and CSF cut-off values at fixed specificities of 90 % and 95 %. RESULTS: Seven out of 38 subjects (18 %) were positive on amyloid PET. Aβ42/ttau, Aβ42/Aβ40, Aβ42/Aβ38, and Aβ42 had the highest accuracy to identify amyloid-positive subjects (area under the curve (AUC) ≥ 0.908). Aβ40 and Aβ38 had significantly lower discriminative power (AUC = 0.571). When specificity was fixed at 90 % and 95 %, Aβ42/ttau had the highest sensitivity among the different CSF markers (85.71 % and 71.43 %, respectively). Sensitivity of Aβ42 alone was significantly lower under these conditions (57.14 % and 42.86 %, respectively). CONCLUSION: For the CSF-based definition of preclinical AD, if a high specificity is required, our data support the use of Aβ42/ttau rather than using Aβ42 in isolation. BioMed Central 2015-12-18 /pmc/articles/PMC4683859/ /pubmed/26677842 http://dx.doi.org/10.1186/s13195-015-0159-5 Text en © Adamczuk et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Adamczuk, Katarzyna Schaeverbeke, Jolien Vanderstichele, Hugo M. J. Lilja, Johan Nelissen, Natalie Van Laere, Koen Dupont, Patrick Hilven, Kelly Poesen, Koen Vandenberghe, Rik Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title | Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title_full | Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title_fullStr | Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title_full_unstemmed | Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title_short | Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease |
title_sort | diagnostic value of cerebrospinal fluid aβ ratios in preclinical alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683859/ https://www.ncbi.nlm.nih.gov/pubmed/26677842 http://dx.doi.org/10.1186/s13195-015-0159-5 |
work_keys_str_mv | AT adamczukkatarzyna diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT schaeverbekejolien diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT vanderstichelehugomj diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT liljajohan diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT nelissennatalie diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT vanlaerekoen diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT dupontpatrick diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT hilvenkelly diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT poesenkoen diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease AT vandenbergherik diagnosticvalueofcerebrospinalfluidabratiosinpreclinicalalzheimersdisease |